**Company Performance:** Financial results like revenue, profit margins, and earnings per share directly influence investor confidence.

**Industry Trends:** The overall health and growth prospects of the biotechnology sector can impact ADC Therapeutics' stock price.

**Clinical Trial Results:** Positive clinical trial data for its cancer therapies typically boosts the stock, while negative results can depress it.

**Regulatory Approvals:** FDA approval of ADC Therapeutics' drugs significantly impacts revenue potential and therefore the stock price.

**Competition:** The emergence of competing cancer treatments can affect ADC Therapeutics' market share and investor sentiment.

**Market Conditions:** Broad economic trends and overall market sentiment influence investor risk appetite and stock valuations.

**Partnerships and Acquisitions:** Strategic collaborations or potential acquisition offers can significantly alter the stock's trajectory.

**Debt and Cash Flow:** The company's financial stability, including its debt levels and cash flow, impacts investor confidence.

**Management Team:** The experience and reputation of ADC Therapeutics' leadership team influence investor trust.

**Analyst Ratings:** Analyst upgrades or downgrades can affect investor perception of the stock's value.